Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. [electronic resource]
Producer: 20110324Description: 1005-15 p. digitalISSN:- 1533-4406
- Administration, Inhalation
- Animals
- Anti-Asthmatic Agents -- adverse effects
- Antibodies, Anti-Idiotypic -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Asthma -- drug therapy
- Child
- Cockroaches -- immunology
- Double-Blind Method
- Drug Therapy, Combination
- Dust -- analysis
- Female
- Glucocorticoids -- administration & dosage
- Humans
- Immunoglobulin E -- blood
- Male
- Omalizumab
- Poverty Areas
- Practice Guidelines as Topic
- Seasons
- Urban Population
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.